Live Breaking News & Updates on Medicines notifications

Changes to MHRA Drug alert titles and classification
The MHRA has made further changes to the way we issue safety messaging to healthcare providers.
From:
Alert type:
NatPSA Update
As an update, we wanted to provide further information to MHRA Defective Medicines Report Centre safety messaging in line with the accreditation of MHRA as an issuer of National Patient Safety Alerts
As previously indicated, the term ‘alert’ will no longer be used for any MHRA safety message which does not meet the criteria of a National Patient Safety Alert.
MHRA Drug Alerts are being renamed to Medicines Recalls (to replace what were previously Drug Alerts class 1-3) and Medicines Notifications (to replace what were previously Drug Alert: Caution in Use, Class 4). All Class 1 Medicines Recalls will meet the National Patient Safety Alert criteria and will be issued as National Patient Safety Alerts (NatPSA). Responses will be collected via the CAS website from NHS Trusts and Foundation Trusts. Any Recalls and Notifications that do not meeting the National Patient Safety Alert criteria will not be published on the CAS website.

National-patient-safety-alert , Defective-medicines-reporting-centre , National-patient-safety , National-patient-safety-alerts-nat , Defective-medicines-report-centre , Medicines-report-centre , Medicines-recalls , Drug-alerts , Medicines-notifications , Drug-alert , All-class